Galectin 3 (LGALS3) (N-Term) Peptid
LGALS3
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Galectin 3 (LGALS3) Produkte
- Galectin 3 (LGALS3)
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- FSLHDALSGS GNPNPQGWPG AWGNQPAGAG GYPGASYPGA YPGQAPPGAY
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LGALS3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Galectin 3 (LGALS3)
- Substanzklasse
- Chemical
- Hintergrund
-
This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. Alternate splicing results in multiple transcript variants.
Alias Symbols: LGALS3, MAC2,
Protein Size: 250 - Gen-ID
- 3958
- NCBI Accession
- NP_002297
- UniProt
- P17931
-
Sie sind hier:
